Pliant Therapeutics Inc (PLRX) Key Ratios
$1.15
As on 03-Sep-2026 10:34EDT
Market cap
$69 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -11.63 | 47.35 | 56.11 | 11.22 | -2.03 |
| Net Profit | -11.63 | 48.33 | 55.41 | 10.82 | -2.88 |
| EPS | -11.42 | 48.78 | 55.88 | 13.26 | 6.08 |
| Book Value | -- | -- | -41.21 | -22.82 | -17.99 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -10,130.95 | -3,886.68 | -- | -- | -- |
| Net Margin
| -- | -568.73 | -- | -- | -- |
| Return on equity
| -52.21 | -42.44 | -56.25 | -61.55 | -54.09 |
| Return on Capital
| -47.05 | -38.91 | -- | -51.98 | -49.53 |
| Return on Assets
| -43.89 | -36.35 | -27.41 | -48.01 | -46.27 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.16 | 0.20 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
-51.98
|
-49.53
|
-39.64
|
-46.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-56.25
Lower than Peers by 75.22
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
-56.25
|
-61.55
|
-54.09
|
-41.00
|
-48.13
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
-27.41
Lower than Peers by 30.27
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
-27.41
|
-48.01
|
-46.27
|
-37.40
|
-43.13
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
-10,130.95
|
-1,265.15
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
-10,211.14
|
-909.18
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
-1.00
|
-0.84
|
0.28
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
56.11
Higher than Peers by 47.85
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
56.11
|
29.19
|
-29.49
|
-30.64
|
-513.08
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
55.41
Higher than Peers by 47.68
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
55.41
|
28.99
|
-30.35
|
-30.83
|
-588.67
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
55.88
Higher than Peers by 45.49
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
55.88
|
0.30
|
-0.29
|
-0.07
|
-4.09
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
-33.81
Lower than Peers by 38.69
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
-33.81
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
0.16
|
0.20
|
0.02
|
0.05
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.02
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
0.02
|
0.01
|
0.00
|
0.00
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
9.90
Higher than Peers by 8.25
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
9.90
|
12.00
|
10.91
|
17.72
|
14.23
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
9.90
Higher than Peers by 8.70
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
9.90
|
--
|
--
|
--
|
14.23
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
-33.40
Lower than Peers by 38.17
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
-33.40
|
-57.36
|
-68.54
|
-126.34
|
-154.91
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
189.68
|
32.46
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
0.00
|
0.03
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
709.81
|
105.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
693.46
|
901.61
|
606.20
|
225.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
103.61
|
-120.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
-0.50
|
-3.79
|
-6.72
|
-7.65
|
|
Peer Median
|
37.32
|
--
|
--
|
--
|
--
|
Price / Book Value
0.49
Lower than Peers by 7.27
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
0.49
|
0.41
|
2.62
|
2.29
|
3.01
|
|
Peer Median
|
7.75
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
EV/EBITDA
-2.54
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
-2.54
|
0.60
|
-2.45
|
-3.80
|
-5.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
69
Lower than Peers by 2,452
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
69
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,521
|
--
|
--
|
--
|
--
|